Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Iktos
French AI-driven drug design firm will employ multiple technology platforms in latest tie-ups. Apellis looks to augment Empaveli-led portfolio in C3 complement R&D alliance with Affilogic.
AstraZeneca licenses bispecific cancer antibody candidate from Harbour Biomed. Regeneron seeks new approach to gene therapy delivery in deal with ViGeneron.
- Research, Analytical Equipment & Supplies
- Artificial Intelligence
- Drug Discovery Tools